To maintain growth, the booming U.S. hemp industry needs a reliable supply of steady, stable seed genetics. Professional and academic plant breeders are rushing to fill the market demand, but it might take at least another five years to develop those genetics, according to longtime breeders. That’s because it takes time to breed, trial and […]
Read More
Featured News
JUST RELEASED
2nd Annual Hemp & CBD Industry Factbook
The most comprehensive and reliable data resource for the hemp and CBD industry available today – and the only report to deliver a complete, end-to-end look at the cannabis supply chain.
ORDER THE 2019 EDITION NOW
More Exclusive Features
Ongoing hemp-transport questions trigger Minnesota warning
A Minnesota hemp industry group is warning manufacturers not to order hemp biomass from other states in the wake of a South Dakota drug arrest of a deliveryman bringing plants from Colorado to Minnesota for extraction. The Minnesota warning comes as a federal appeals court prepares to hear arguments next week over hemp transportation. “The ability […]
Read More
‘Sky is the limit’ for global hemp opportunities: Q&A with Hemp Industries Association’s Joy Beckerman
Hemp is a global industry and the passage of the 2018 Farm Bill put the United States on the map as a major player ready to compete, with the potential to impact the international business scene with its unique capabilities.
Read More
Sweet strategy: How one CBD manufacturer found success making ingredients, not edibles
Azuca, a CBD-infused product manufacturer headquartered in New York City, is using tiny, infused sugar granules as the building blocks for its rapidly growing cannabis business.
Read More
USDA: National THC test for hemp ‘as challenging as you think it is’
Federal agriculture authorities are struggling to craft a nationwide THC testing standard so that state and local regulators can tell hemp from marijuana, complicating the release of standardized production rules, according to an official with the U.S. Department of Agriculture (USDA). William Richmond, head of the Specialty Crops Program in the USDA’s Agricultural Marketing Service, […]
Read More
Beyond the Dispensary: 5 strategies CBD brands use to make deals with mainstream retailers
Mainstream retailers are contributing to the validation of the CBD category as national store chains continue to join the movement, driven by consumer demand and interest.
Read More
‘The FDA is struggling’: Former US surgeon general Carmona on government’s approach to CBD
The booming CBD industry is eagerly waiting to see if U.S. health regulators change course and start allowing cannabinoid treatments in food and dietary supplements. Many are hoping the U.S. Food and Drug Administration (USDA) will condone over-the-counter CBD products while setting production and purity standards to eliminate inferior CBD products from the market. Against […]
Read More
Damaging hailstorm hits Oregon hemp farms, causes potentially millions in losses
Hemp farmers in Central Oregon were faced with a situation no grower wants to see on Aug. 9, when severe thunderstorms in the area dumped golf ball-sized hail onto their fields. Deschutes County Farm Bureau President Matt Cyrus, who also operates Triple C Farms, a hemp farm near Sisters, estimates that 400-500 acres between Cline […]
Read More
Chinese tariffs having minimal effects on US hemp industry, experts say
Most American farmers are in full-fledged panic mode after companies in China suspended their use of U.S. agricultural products in response to tariffs imposed by the Trump administration on Chinese goods. But the nascent U.S. hemp industry shouldn’t worry, economists and trade experts told Hemp Industry Daily. A $5.9 billion market, China is one of […]
Read More
Hemp in California: Clock ticking to get bills to governor’s desk
California has lagged behind other states in passing hemp policy. That could change in the next month.
Read More
Strong CBD drug release powers GW Pharmaceuticals’ record revenue
Strong patient interest in the only federally approved CBD product in the United States helped drugmaker GW Pharmaceuticals record $72 million in revenue last quarter. Epidiolex, a seizure control drug approved by the U.S. Food and Drug Administration, has seen brisk sales and new patient enrollments since the drug’s launch last November. GW Pharma (Nasdaq: GWPH) reported that […]
Read More